Inspire Medical Has $10B Annual Market Opportunity, Stifel Says In Bullish Initiation


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Not a month into Inspire Medical Systems Inc (NYSE:INSP)’s life as a publicly traded company, the Street is coming to consensus.

Two bulls and a fence-sitter issued their opinions Tuesday.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

The Rating

Stifel Nicolaus analyst Jonathan Block initiated coverage of Inspire with a Buy rating and $42 price target.

The Thesis

Stifel considers Inspire’s competitive clinical data robust enough to win commercial payors.

“We believe Inspire Medical Systems is well positioned to disrupt the obstructive sleep apnea market over the next several years,” Block said in a note. He estimates a $10-billion annual opportunity in OSA alone. 


FREE REPORT: How To Learn Options Trading Fast

In this special report, you will learn the four best strategies for trading options, how to stay safe as a complete beginner, ​a 411% trade case study, PLUS how to access two new potential winning options trades starting today.Claim Your Free Report Here.


At the same time, the analyst anticipates Upper Airway Stimulation volume growth among existing prescribers of 68 percent and 47 percent in 2018 and 2019, respectively, based on conversations with physicians using the system.

“Additionally, our data clearly highlights the surgeon’s preference for Inspire’s UAS over that of UPPP (a more invasive surgical procedure), which is an estimated $1-billion market opportunity,” Block said. 

Stifel projects “significant” opportunity for the procedure to gain general market share as well as traction among pediatric patients with Down Syndrome.

Price Action

Inspire shares were down 4.6 percent at the time of publication Tuesday morning.

Related Links:

WHO Deems The Products Of These Diagnostic Companies 'Essential'

The Week Ahead In Biotech: ASCO Presentations In The Spotlight

Photo courtesy of Inspire Medical. 


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Posted In: Analyst ColorHealth CarePrice TargetInitiationAnalyst RatingsGeneralJonathan BlockStifel Nicolaus